RadNet, Inc.

NASDAQ:RDNT

Medical - Diagnostics & Research

Healthcare
$71.82 +2.90%

+$1.53 today

Market cap
$5.66B
Beta
1.39
P/E (TTM)
-295.1
EPS (TTM)
-$0.18
52W Low $50.76High $85.84

Volume 0.81M

Average 0.80M

RDNT Operating Income

Profit from core operations after operating expenses, before interest and taxes.

RadNet, Inc.NASDAQ: RDNT

Operating Income · Q3 FY2026 · quarter ended Sep 2026

Operating income dips below year-ago levels

Q3 FY2026 operating income of $30.26M fell 7.4% year over year, behind the +38.2% change in trailing-twelve-month operating income. Sequentially, it fell 23.3% from the prior quarter. Over 3 fiscal years it compounded at +25.1% a year.

Context

  • Operating income amounted to 4.5% of revenue in FY2025, down 1.3 pp from a year earlier.
  • Operating income increased in 2 of the last 3 fiscal years.

What to watch

Whether operating income reaches the consensus estimate from 4 analysts of $131.94M (+45.3%) for the fiscal year ending Dec 2026, a step up from the -13.2% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$30.26M-23.3% QoQ
Last fiscal yearDec 2025
$90.8M-13.2% YoY
LTMSep 2026
$88.41M+38.2% YoY
Operating Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-7.4%+30.8%+38.3 pp
1 year-13.2%+45.3%+58.5 pp
3-year CAGR+25.1%+26.9%+1.8 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Income history

USD · from the income statement

Latest · FY2025
90.8M USD
Year-over-year change
-13.2%
4-year CAGR
+2.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Income vs competitors

How RDNT compares with its peers on the latest reported figures

  • RDNT's LTM Sep 2026 operating income of $88.41M is the 3rd highest of the 7 companies compared; the peer median is $27.34M.
  • Its year-over-year change of +38.2% is the highest of 7, against a peer median of -11.5%.
  • Operating income amounts to 3.7% of revenue for RDNT, versus a peer median of 22.5%.
RDNT Competitors Peer median
Operating Income for RDNT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$2.57B -6.8%+3.1%12.7%
BRKRBruker CorporationLTM Jun 2026$126.5M -31.2%-18.3%3.6%
RDNTRadNet, Inc.LTM Sep 2026$88.41M +38.2%+25.1%3.7%
IRMDIRadimed CorporationLTM Mar 2026$27.95M +23.4%+18.7%32.4%
LMRILumexa Imaging Holdings, Inc. Common StockFY2025$26.73M -51.6%—2.6%
NNOXNano-X Imaging Ltd.LTM Dec 2025-$60.7M -7.0%—466.2%
BFLYButterfly Network, Inc.LTM Mar 2026-$81.44M -15.9%—79.1%
Peer median (excluding RDNT) $27.34M-11.5%+3.1%22.5%

Competitors are the stored peer set for RDNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.32B1.43B1.62B1.83B2.04B
Cost of Revenue1.12B1.26B1.4B1.58B1.95B
Gross Profit191.8M165.72M221.39M249.12M90.8M
Gross Margin14.6%11.6%13.7%13.6%4.5%
Research & Development00000
Selling, General & Admin00000
Operating Expenses109.25M119.35M122.69M144.49M0
Depreciation & Amortization170.66M184.72M189.49M137.84M152.13M
EBITDA278.37M278.53M292.79M262.55M253.95M
EBITDA Margin21.2%19.5%18.1%14.3%12.4%
Operating Income82.55M46.36M98.7M104.62M90.8M
Operating Margin6.3%3.2%6.1%5.7%4.5%
Interest Income00000
Interest Expense48.83M50.84M64.48M79.85M69.91M
Other Income / Expenses(23.68M)(3.39M)(59.89M)(59.76M)(58.9M)
Income Before Tax58.88M42.97M38.81M44.86M31.91M
Pre-Tax Margin4.5%3.0%2.4%2.5%1.6%
Income Tax Expense14.56M9.36M8.47M6.03M14.86M
Net Income24.73M10.65M3.04M2.79M(18.65M)
Net Margin1.9%0.7%0.2%0.2%-0.9%
EPS (Basic)0.470.190.050.04(0.25)
EPS (Diluted)0.460.170.050.04(0.25)
Weighted Avg Shares52.5M56.29M63.58M73.04M75.19M
Weighted Avg Shares (Diluted)53.42M57.32M64.66M74.76M75.19M

RadNet, Inc.

NASDAQ:RDNT

Intrinsic Alpha fair value

Locked

Current Price

$71.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.